Article

STAAR Surgical announces management additions, promotions

The company promotes two and adds another employee as it names three vice presidents.

Monrovia, CA-STAAR Surgical Co. has announced several additions to its senior management team.

James Francese has joined the company as vice president of global development; Robin Hughes has been named vice president of research and development, regulatory and quality; and Craig Felberg has been named vice president of business development.

“These leadership transitions are designed to help fuel our revenue growth in three ways: more effectively and aggressively market STAAR products globally, bring new products to market more quickly, and evaluate additional new technologies and business opportunities [that] will allow us to grow within our area of strategic focus,” said Barry Caldwell, STAAR chief executive officer.

Francese has 22 years of experience in ophthalmology, including 14 years marketing surgical products with Abbott Medical Optics (AMO) and Allergan. During his time at AMO, he served as head of marketing, Americas, for all surgical, refractive, and corneal products; head of global corneal marketing, responsible for all consumer products; and vice president of the Asia Pacific region.

Hughes has more than 20 years of experience in the ophthalmic industry, including the past 5 years as vice president of global marketing at STAAR.

Felberg has 30 years of experience in the ophthalmic surgical business, including the past 5 years as vice president of research and development at STAAR.

For more articles in this issue of Ophthalmology Times eReport, click here.

Related Videos
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
© 2025 MJH Life Sciences

All rights reserved.